Novanta (NASDAQ:NOVT – Get Rating) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 9th. Analysts expect the company to announce earnings of $0.72 per share for the quarter. Novanta has set its Q2 guidance at $0.69 to $0.73 EPS and its Q2 2022 guidance at $0.69-$0.73 EPS.Investors that wish to register for the company’s conference call can do so using this link.
Novanta (NASDAQ:NOVT – Get Rating) last issued its quarterly earnings results on Tuesday, May 10th. The technology company reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.10. The company had revenue of $204.20 million for the quarter, compared to analyst estimates of $195.96 million. Novanta had a return on equity of 19.41% and a net margin of 7.73%. The company’s revenue for the quarter was up 25.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.58 EPS. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Novanta Stock Down 0.9 %
Shares of NOVT opened at $152.87 on Tuesday. The company has a market capitalization of $5.46 billion, a PE ratio of 94.36 and a beta of 1.16. The company has a current ratio of 2.05, a quick ratio of 1.29 and a debt-to-equity ratio of 0.77. The stock’s 50-day moving average price is $126.26 and its two-hundred day moving average price is $131.51. Novanta has a 12 month low of $110.84 and a 12 month high of $184.44.
Institutional Investors Weigh In On Novanta
Analyst Ratings Changes
Several research firms have recently issued reports on NOVT. TheStreet lowered Novanta from a “b-” rating to a “c+” rating in a report on Wednesday, June 1st. William Blair upgraded Novanta from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 11th.
Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
- Get a free copy of the StockNews.com research report on Novanta (NOVT)
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- Deep Value High Yield Newell Brands Is Ready To Bottom
- The Colgate-Palmolive Growth Outlook Brightens
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.